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BROADENED AND ELEVATED HUMORAL
IMMUNE RESPONSE TO EBNA1 IN PEDIATRIC
MULTIPLE SCLEROSIS
Epidemiologic studies suggest that childhood viral
exposures are important determinants of multiple
sclerosis (MS) risk in both adults and children1 and,
so far, Epstein-Barr virus (EBV) stands out as the
infectious agent for which there is the most compel-
ling evidence for an association with the disease.1-3
Patients, healthy donors, and methods. Twenty-
three children with a diagnosis of definite MS and 17
demographically matched healthy peers were en-
rolled at the Department of Pediatrics and Pediatric
Neurology, University of Go¨ttingen, Germany (table
e-1 on the Neurology® Web site at www.neurology.
org). Virus-specific antibody responses were assessed
using standardized ELISA kits (Bio-Quant, San Di-
ego, CA) for IgG antibodies directed against the EBV-
encoded viral capsid antigen (EBV-VCA), the
HCMV-derived early antigens (HCMV-EA), the
immunogenic C-terminus of the latent EBV nuclear
antigen-1 (EBNA1, aa 458-641), and toward EBV-
infected B cell lysates.4 In order to assess the specific-
ity of EBNA1-targeting IgG, 211 dodecamer
peptides, overlapping by nine amino acids and cover-
ing the entire sequence of EBNA1 (aa 1-641), were
covalently linked to cellulose membranes as de-
scribed previously.5 Positive spots were identified as
blue or purple. Individual membranes were pro-
cessed and evaluated blinded to the clinical diagnosis.
Results. A total of 91% and 87% of MS cases com-
pared to 64% and 58% of controls showed IgG re-
sponses toward EBV-VCA and EBNA1, respectively.
The frequency of HCMV-EA seropositivity did not
differ between both cohorts. IgG titers to EBV-VCA,
EBV-infected B cell lysates which predominantly
contain lytic EBV antigens,6 and to HCMV-EA did
not significantly differ between the cohorts (figure,
A). By contrast, children with MS showed a moder-
ate but significant increase of EBNA1-specific IgG1
antibody titers (p 0.02) (figure, B). The difference
in EBNA1 recognition between patients and controls
was preserved after eliminating the samples derived
from treated patients (8/23) from our analysis (p 
0.03). These data suggest a primary deregulation of
EBNA1-, but not generally of EBV-specific immune
responses in pediatric MS.
We next determined target epitopes of EBNA1-
specific IgG in 10 patients and 10 controls, in whom
IgG responses to EBNA1 were detectable by ELISA
(figure, C). The overall titer of EBNA1-specific IgG
antibodies, including all IgG isotypes, did not statis-
tically differ between these subgroups (mean IgG ti-
ter  SEM in MS vs HD: 1,024  152 vs 711 
106, p 0.15). Antibody specificities were primarily
directed toward the glycine-alanine repeat domain of
EBNA1 (aa 88-323). In addition, pediatric MS sera
bound to distinct epitopes which were not recog-
nized by any of the control sera. However, the broad-
ened recognition of EBNA1-specific IgG was not
restricted to a distinct part of the antigen. As shown
in the figure, D, patients recognized a higher number
of epitopes within all three domains of the protein
(p  0.0001). Although we cannot completely ex-
clude that the broadening of the antibody response
resulted from the elevated IgG1 titers, we consider
this explanation unlikely, because the overall immu-
noglobulin levels for EBNA1 were not increased in
this subgroup of patients. Instead, our data point to-
ward an upregulated and qualitatively distinct im-
mune recognition of EBNA1 in children with MS.
Discussion. EBNA1 is the only EBV antigen con-
sistently expressed in proliferating EBV-infected B
cells of healthy virus carriers. Increased titers of
EBNA1-specifc antibodies were found to be associ-
ated with various autoimmune diseases including
SLE and MS1 as well as more recently with pediatric
SLE and pediatric MS.2 Cepok et al.7 reported that
the two most frequent MS-specific and high affinity
epitopes, recognized by CSF-derived oligoclonal IgG
in MS, are both derived from EBV, i.e., EBNA1 and
BRRF2, suggesting that EBNA1-specific antibodies
are not only systemically elevated in MS, but also
enriched in the CSF.
EBNA1 represents a key target antigen for CD4
T cell-mediated immune control of latent EBV in-
fection and we suggest that the observed quantita-
tively and qualitatively altered IgG1 responses to
EBNA1 in pediatric patients with MS reflect the
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finding that adult patients show increased frequen-
cies and broadened specificities of EBNA1-specifc
CD4 T helper 1 cells.3 Increased availability of
EBNA1 protein due to higher frequencies of EBV-
infected and potentially autoreactive B cells in MS or
continuous cross-stimulation of EBNA1-specific T
cells by a disease-relevant autoantigen could trigger a
selective increase of EBNA1-targeting immune re-
sponses in pediatric and adult MS.
We conclude that the increase and broadened rec-
ognition of EBNA1-specific IgG suggests an early
dysregulation of EBV specific immune control in pe-
diatric MS development. Further studies are neces-
sary to elucidate the mechanisms by which altered
EBV and in particular EBNA1-specific immune re-
sponses could potentially contribute to the early
pathobiology of MS.
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Figure Broadened and elevated humoral immune response to EBNA1 in pediatric MS
Children with MSweremore frequently infected with EBV than age-matched healthy individuals, but they had similar titers
of EBV-VCA, EBV-infected cell lysate, and HCMV-EA binding IgG antibodies (A). In contrast, pediatric MS patients showed
an increase of EBNA1-specific IgG1, but not of IgG2, IgG3, or IgG4 EBNA1-specific antibody titers (p  0.02; Mann
Whitney test) (B). Neither patients nor controls showed EBNA1-specifc IgG3 seropositivity. IgG2 and IgG4 responses to
EBNA1 were detected in a minor subgroup of pediatric MS cases and controls with no statistically significant difference
between both cohorts. To explore qualitative differences in the immune recognition of EBNA1 between untreated children
with and without MS, we determined target epitopes of EBNA1-specific IgG by using membranes carrying spots of 211
covalently linked overlapping dodecamer peptides which cover the entire sequence of EBNA1 (aa 1–641) (C). The three
main domains of EBNA1 (N-terminal, GA-repeat, and C-terminal) are outlined in the primary protein sequence (figure e-1),
and the number of peptides recognized in these different domains by patients with MS and healthy controls is displayed in
D. Percentages below bars in panel D represent the frequency of peptides recognized compared to all EBNA1-derived
peptides. MS multiple sclerosis; EBV  Epstein-Barr virus; EBNA1  EBV nuclear antigen-1; EBV-VCA  EBV-encoded
viral capsid antigen; HCMV-EA human cytomegalovirus–derived early antigens; Ig immunoglobulin.
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TWO SETS OF IDENTICAL TWINS WITH CERVICAL
ARTERY DISSECTION CONCORDANT FOR
TEMPORALARTERYPATHOLOGY
The etiology of spontaneous cervical artery dissection
(sCAD) is largely unknown.1,2 Approximately 15% of
patients with sCAD develop multiple sCAD either si-
multaneously or in short succession.3 Therefore, we hy-
pothesized that patients with sCAD are generally
susceptible to dissection and that this predisposition
manifests itself in the arterial wall. Previously, we dem-
onstrated signs of a generalized arteriopathy in superfi-
cial temporal artery (STA) biopsies of patients with
sCADbut not of controls.4 In this study we investigated
STA and skin biopsies of two pairs of identical twins in
whom one twin of each pair had had a sCAD.
Case reports. Twin 1.1 was 56 years old at the time of
the dissection. He experienced severe dizziness, nausea,
and vomiting preceding admission. He presented with
left sided Horner syndrome only. MRI showed no
brain infarct but a long dissection reaching from close to
the bifurcation of the left internal carotid artery to the
base of the skull. The skin and STA biopsies were per-
formed 9 months after the dissection.
Twin 1.2 is the healthy brother of 1.1. Ultra-
sound examination showed no dissection.
Twin 2.1 was 49 years old at the time of the dissec-
tion. He experienced right-sided facial pain during the
night preceding admission. The following morning he
noticed a left-sided facial weakness and clumsiness of his
left hand. He presented with right-sided Horner syn-
drome and minimal left-sided brachiofacial hemipare-
sis. MRI showed a partial middle cerebral artery infarct
on the right side and revealed a mural hematoma of the
right internal carotid artery. The skin and STA biopsies
were performed 8months after the dissection. A asymp-
tomatic aneurysm (2.8  3.0 cm) of his left common
iliac artery was detected by ultrasound.
Twin 2.2 is the healthy brother of 2.1. Ultrasound
examination of the cervical arteries did not show a
dissection.
None of the four brothers showed clinical signs of
a connective tissue disorder.
Laboratory investigations. DNA analysis proved
that both twin pairs were monozygous. The skin bi-
opsies of all four twin brothers did not show any
severe connective tissue abnormalities.5 The figure,
A, shows the structurally intact arterial wall of the
STA of a control subject (control C24). Vascular
smooth muscle cells (SMC) were of the physiologic
contractile phenotype and neither fresh nor degraded
erythrocytes or other cellular debris were found. In
contrast, light microscopy of the STA biopsies of the
two index twins with sCAD (twins 1.1 and 2.1)
showed a zone of structural weakening along the
medial-adventitial border (figure, F and H) and
breakdown of SMC. The media and adventitia of
companion twins without sCAD (twins 1.2 and 2.2)
also showed, unlike the previously described unre-
lated controls,4 structural aberrations along the
medial-adventitial border (figure, G and I, encir-
cled). Erythrocytes located outside of vasa vasorum
were found in all four twin brothers (figure, H inset,
I). The pathologic findings on electron microscopy
of all four twin brothers were comparable to our pre-
vious findings in patients with sCAD. SMC often
showed a synthetic phenotype and signs of cellular
breakdown. Scattered erythrocytes at various stages
of degradation and cellular remnants were found
(figure, I). An overt microhematoma at the medial-
adventitial border coming close but not penetrating
the intima was present in index twin 2.1 (figure, B
and C). Immune cells along the border of the hema-
toma had already phagocytosed erythrocytes demon-
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